Virtus ETF Advisers’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-15,557
| Closed | -$301K | – | 399 |
|
|
2018
Q3 | $301K | Sell |
15,557
-11,306
| -42% | -$219K | 0.03% | 186 |
|
|
2018
Q2 | $486K | Buy |
26,863
+9,567
| +55% | +$173K | 0.43% | 136 |
|
|
2018
Q1 | $184K | Buy |
17,296
+9,010
| +109% | +$95.9K | 0.16% | 117 |
|
|
2017
Q4 | $349K | Buy |
8,286
+6,517
| +368% | +$274K | 0.44% | 90 |
|
|
2017
Q3 | $97K | Buy |
1,769
+162
| +10% | +$8.88K | 0.01% | 141 |
|
|
2017
Q2 | $298K | Sell |
1,607
-1,181
| -42% | -$219K | 0.04% | 125 |
|
|
2017
Q1 | $333K | Buy |
2,788
+268
| +11% | +$32K | 0.06% | 127 |
|
|
2016
Q4 | $250K | Buy |
2,520
+137
| +6% | +$13.6K | 0.07% | 143 |
|
|
2016
Q3 | $267K | Hold |
2,383
| – | – | 0.13% | 118 |
|
|
2016
Q2 | $245K | Buy |
2,383
+811
| +52% | +$83.4K | 0.18% | 94 |
|
|
2016
Q1 | $144K | Buy |
+1,572
| New | +$144K | 0.2% | 125 |
|